Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,44 USD | -1,25% | +12,19% | -15,37% |
Omzet 2024 * | 24,07 mln. 22,37 mln. | Omzet 2025 * | 42,86 mln. 39,82 mln. | Marktkapitalisatie | 62,09 mln. 57,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -61 mln. -56,68 mln. | Nettowinst (verlies) 2025 * | -40 mln. -37,17 mln. | EV/omzet 2024 * | 2,58 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,45 x |
K/w-verhouding 2024 * |
-1,06
x | K/w-verhouding 2025 * |
-2,49
x | Werknemers | 69 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,66% |
Recentste transcriptie over Cidara Therapeutics, Inc.
1 dag | +8,79% | ||
1 week | +10,43% | ||
Lopende maand | +13,61% | ||
1 maand | -41,34% | ||
3 maanden | +1,40% | ||
6 maanden | -14,94% | ||
Lopend jaar | -14,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 01-09-21 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 01-04-14 |
Director/Board Member | 69 | 01-04-14 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-05-24 | 13,44 | -1,25% | 40 475 |
06-05-24 | 13,61 | +8,79% | 102 155 |
03-05-24 | 12,51 | -1,34% | 54 051 |
02-05-24 | 12,68 | +7,37% | 65 150 |
01-05-24 | 11,81 | -1,42% | 107 666 |
uitgestelde koers Nasdaq, 06 mei 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,29% | 62,09 mln. | |
+9,15% | 106 mld. | |
-1,08% | 104 mld. | |
+6,26% | 23,25 mld. | |
-11,55% | 22,5 mld. | |
-7,01% | 18,7 mld. | |
-37,08% | 17,95 mld. | |
-9,91% | 16,99 mld. | |
+7,55% | 14,26 mld. | |
+40,04% | 12,76 mld. |